Sivasundaram Karnan
Nagakute, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Nintedanib inhibits the VEGFR-ERK signaling pathway in human KRAS-mutated cancer cells.
Journal: Cell death & disease
Published: January 20, 2026
Successes and Challenges of Bispecific T-cell Engager Antibodies in the Treatment of Multiple Myeloma.
Journal: Internal medicine (Tokyo, Japan)
Published: December 10, 2025
Rho kinase 2 promotes epithelial-mesenchymal transition and proliferation in human prostate cancer PC-3 cells.
Journal: Journal of pharmacological sciences
Published: May 24, 2025
Primary Plasma Cell Leukemia: Recent Advances in Molecular Understanding and Treatment Approaches.
Journal: International journal of molecular sciences
Published: May 12, 2025
Characterization of targeted knock-in achieved via tandem paired nicking mediated by CRISPR/Cas9 nickases.
Journal: Methods (San Diego, Calif.)
Published: February 27, 2025
Targeting fatty acid synthase suppresses tumor development in NF2/CDKN2A-deficient pleural mesothelioma.
Journal: Cell death & disease
Published: February 11, 2025
Diffuse Large B-Cell Lymphoma with t(1;22)(q21;q11.2) and t(6;18)(p25;q21): A Case Report.
Journal: Reports (MDPI)
Published: November 29, 2024
ARK5 enhances cell survival associated with mitochondrial morphological dynamics from fusion to fission in human multiple myeloma cells.
Journal: Cell death discovery
Published: June 22, 2023
CAMK2D: a novel molecular target for BAP1-deficient malignant mesothelioma.
Journal: Cell death discovery
Published: December 05, 2022
Last Updated: 09/26/2026